Home › Pulmonary Arterial Hypertension › South Carolina
Pulmonary Arterial Hypertension clinical trials in South Carolina
4 studies for Pulmonary Arterial Hypertension are looking for participants at sites in South Carolina.
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- USA007, Anderson
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 16, 2026 · NCT07481981Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Medical University of South Carolina - Nexus Research Center, Charleston
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06274801Pulmonary Hypertension Association Registry
- AnMed Health, Anderson
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Medical University of South Carolina, Charleston
Recruiting
Ages 18 and older · All sexes · Updated Sep 29, 2025 · NCT04555161From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.